Expertise in
10
conditions

Dr. Ahmad H. Mattour

Hematology Oncology | Hematology | Internal Medicine
Henry Ford Cancer-Detroit
2800 W Grand Blvd, 
Detroit, MI 
Accepting New Patients
Offers Telehealth
Expertise in
10
conditions
Henry Ford Cancer-Detroit
2800 W Grand Blvd, 
Detroit, MI 

Overview

Ahmad Mattour is a Hematologist Oncology specialist and an Internal Medicine provider practicing medicine in Detroit, Michigan.

Dr. Mattour is highly rated in 10 conditions, according to our data. His clinical expertise encompasses Large-Cell Immunoblastic Lymphoma, Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, Bone Marrow Aspiration, and Gastrostomy.

He is actively involved in clinical research, co-authoring 4 peer reviewed articles and participating in 3 clinical trials. Dr. Mattour is currently accepting new patients.

Specialties

Hematology Oncology
Hematology
Internal Medicine

Licenses

Internal Medicine in MI

Hospital Affiliations

Henry Ford Health Hospital
Henry Ford Health West Bloomfield Hospital
Henry Ford Macomb Hospital
Wyandotte Hospital And Medical Center

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareSource
  • HMO
Cigna
  • EPO
  • HMO
  • PPO
Health Alliance Plan
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
McLaren Health
  • HMO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Meridian Choice
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Priority Health
  • HMO
  • POS
Spectrum Priority Health
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 10 Less Insurance Carriers -

Locations

Henry Ford Cancer-Detroit
2800 W Grand Blvd, Detroit, MI 48202
Other Locations
Henry Ford Medical Center-Fairlane
19401 Hubbard Dr, Dearborn, MI 48126

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Phase 1/2 Study of TAK-981 in Combination With Rituximab in Patients With Relapsed/Refractory CD20-Positive Non-Hodgkin Lymphoma
Phase 1/2 Study of TAK-981 in Combination With Rituximab in Patients With Relapsed/Refractory CD20-Positive Non-Hodgkin Lymphoma
Enrollment Status: Terminated
Publish Date: June 14, 2024
Intervention Type: Drug
Study Drugs: TAK-981, Rituximab
Study Phase: Phase 1/Phase 2
A Phase 1 Open-Label, Safety, Pharmacokinetic and Preliminary Efficacy Study of STRO-001, an Anti-CD74 Antibody Drug Conjugate, in Patients With Advanced B-Cell Malignancies
A Phase 1 Open-Label, Safety, Pharmacokinetic and Preliminary Efficacy Study of STRO-001, an Anti-CD74 Antibody Drug Conjugate, in Patients With Advanced B-Cell Malignancies
Enrollment Status: Completed
Publish Date: June 11, 2024
Intervention Type: Drug
Study Drug: STRO-001
Study Phase: Phase 1
An Open-label, Multi-center, Expanded Treatment Protocol of Midostaurin (PKC412) in Adult Patients With Newly Diagnosed Fms-like Tyrosine Kinase Receptor (FLT3) Mutated Acute Myeloid Leukemia (AML) Who Are Eligible for Standard Induction and Consolidation Chemotherapy.
An Open-label, Multi-center, Expanded Treatment Protocol of Midostaurin (PKC412) in Adult Patients With Newly Diagnosed Fms-like Tyrosine Kinase Receptor (FLT3) Mutated Acute Myeloid Leukemia (AML) Who Are Eligible for Standard Induction and Consolidation Chemotherapy.
Enrollment Status: No_longer_available
Publish Date: July 15, 2020
Intervention Type: Drug
View 2 Less Clinical Trials

4 Total Publications

The Impact of an Outpatient Urgent Care Clinic on Patients Treated for Head and Neck Cancer.
The Impact of an Outpatient Urgent Care Clinic on Patients Treated for Head and Neck Cancer.
Journal: Clinical journal of oncology nursing
Published: June 02, 2026
Similar Doctors
Expertise in
24
conditions
Expertise in
24
conditions
Referral may be required

Karmanos Cancer Center

4100 John R St, 
Detroit, MI 
 (1.6 miles away)
313-576-8730
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Jeffrey Zonder is a Hematologist practicing medicine in Detroit, Michigan. Dr. Zonder is highly rated in 24 conditions, according to our data. His clinical expertise encompasses Multiple Myeloma, Primary Amyloidosis, Relapsed Refractory Multiple Myeloma (RRMM), Bone Marrow Transplant, and Vertebroplasty. Dr. Zonder is currently accepting new patients.

Expertise in
20
conditions
Expertise in
20
conditions
Referral may be required

Karmanos Cancer Center

4100 John R St, 
Detroit, MI 
 (1.6 miles away)
800-527-6266
Languages Spoken:
English, Mandarin, Thai
See accepted insurances
Accepting New Patients

Voravit Ratanatharathorn is a Hematologist practicing medicine in Detroit, Michigan. Dr. Ratanatharathorn is highly rated in 20 conditions, according to our data. His clinical expertise encompasses Multiple Myeloma, Myelodysplastic Syndrome (MDS), Acute Myeloid Leukemia (AML), Graft Versus Host Disease (GvHD), and Bone Marrow Transplant. Dr. Ratanatharathorn is currently accepting new patients.

Expertise in
32
conditions
Dr. Jay Yang
Hematology
Expertise in
32
conditions
Dr. Jay Yang
Hematology
Referral may be required

Office

4100 John R St, 
Detroit, MI 
 (1.6 miles away)
800-527-6266
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Jay Yang is a Hematologist practicing medicine in Detroit, Michigan. Dr. Yang is highly rated in 32 conditions, according to our data. His clinical expertise encompasses Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Leukemia, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Yang is currently accepting new patients.

Frequently Asked Questions about Dr. Ahmad H. Mattour

How do I make an appointment with Dr. Ahmad H. Mattour?

You can book an appointment with Dr. Ahmad H. Mattour by calling their office at 888-777-4167. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Ahmad H. Mattour a top-rated expert for Large-Cell Immunoblastic Lymphoma?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Ahmad H. Mattour is classified as an Advanced expert for Large-Cell Immunoblastic Lymphoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Ahmad H. Mattour specialize in?

While Dr. Ahmad H. Mattour is a Hematology Oncology, they have specific expertise in Large-Cell Immunoblastic Lymphoma, Acute Myeloid Leukemia (AML), and Acute Myeloblastic Leukemia without Maturation. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology Oncology.

Does Dr. Ahmad H. Mattour participate in research or clinical trials?

Yes. Dr. Ahmad H. Mattour has published 4 articles and abstracts on conditions like Large-Cell Immunoblastic Lymphoma. You can view a list of Dr. Ahmad H. Mattour's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Ahmad H. Mattour accept my insurance?

Dr. Ahmad H. Mattour accepts most major insurance plans, including Aetna and Blue Cross Blue Shield. We recommend calling the office directly at 888-777-4167 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Mattour's expertise for a condition
ConditionClose
      View All 10 Advanced Conditions
      View All 49 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile